{"id":"https://openalex.org/W2910694408","doi":"https://doi.org/10.2147/ndt.s169369","title":"Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy","display_name":"Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy","alternate_titles":[],"publication_year":2019,"publication_date":"2019-01-01","ids":{"openalex":"https://openalex.org/W2910694408","doi":"https://doi.org/10.2147/ndt.s169369","mag":"2910694408","pmid":"https://pubmed.ncbi.nlm.nih.gov/30697049","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6339638"},"language":"en","primary_location":{"id":"doi:10.2147/ndt.s169369","doi":"https://doi.org/10.2147/ndt.s169369","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ndt.s169369","pdf_url":"https://www.dovepress.com/getfile.php?fileID=47538","source":{"id":"https://openalex.org/S124245730","display_name":"Neuropsychiatric Disease and Treatment","issn_l":"1176-6328","issn":["1176-6328","1178-2021"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychiatric Disease and Treatment","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2910694408"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=47538","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034274600","display_name":"Kristen M. Ward","orcid":"https://orcid.org/0000-0002-5881-3456","observed_orcids":["https://orcid.org/0000-0002-5881-3456"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristen Ward","raw_affiliation_strings":["Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI, USA"],"raw_orcid":"https://orcid.org/0000-0002-5881-3456","affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013970045","display_name":"Leslie Citrome","orcid":"https://orcid.org/0000-0002-6098-9266","observed_orcids":["https://orcid.org/0000-0002-6098-9266"]},"institutions":[{"id":"https://openalex.org/I181190671","display_name":"New York Medical College","ror":"https://ror.org/03dkvy735","country_code":"US","type":"education","lineage":["https://openalex.org/I181190671"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Leslie Citrome","raw_affiliation_strings":["Department of Psychiatry and Behavioral Science, New York Medical College, Valhalla, NY, USA, citrome@cnsconsultant.com","Department of Psychiatry and Behavioral Science, New York Medical College, valhalla, NY, USA"],"raw_orcid":"https://orcid.org/0000-0002-6098-9266","affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Behavioral Science, New York Medical College, Valhalla, NY, USA, citrome@cnsconsultant.com","institution_ids":["https://openalex.org/I181190671"]},{"raw_affiliation_string":"Department of Psychiatry and Behavioral Science, New York Medical College, valhalla, NY, USA","institution_ids":["https://openalex.org/I181190671"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5013970045"],"corresponding_institution_ids":["https://openalex.org/I181190671"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":30.1763,"has_fulltext":true,"cited_by_count":185,"citation_normalized_percentile":{"value":0.99873401,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"Volume 15","issue":null,"first_page":"247","last_page":"257"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brexpiprazole","display_name":"brexpiprazole","score":1.0},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9800000190734863},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.9179999828338623},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.9909999966621399},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":0.906000018119812},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9309999942779541},{"id":"https://openalex.org/keywords/akathisia","display_name":"akathisia","score":0.9729999899864197},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.9750000238418579},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.9259999990463257},{"id":"https://openalex.org/keywords/antipsychotic-efficacy","display_name":"antipsychotic efficacy","score":0.6880000233650208}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9643831849098206},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.7110415101051331},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.4698100686073303},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.43432867527008057},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3984057605266571},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.35710281133651733},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14849328994750977},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.04720163345336914},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.0}],"mesh":[],"locations_count":7,"locations":[{"id":"doi:10.2147/ndt.s169369","doi":"https://doi.org/10.2147/ndt.s169369","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ndt.s169369","pdf_url":"https://www.dovepress.com/getfile.php?fileID=47538","source":{"id":"https://openalex.org/S124245730","display_name":"Neuropsychiatric Disease and Treatment","issn_l":"1176-6328","issn":["1176-6328","1178-2021"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychiatric Disease and Treatment","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5329640","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6339638","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:30697049","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30697049","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychiatric disease and treatment","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6339638","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6339638/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychiatr Dis Treat","raw_type":"Text"},{"id":"pmh:oai:touroscholar.touro.edu:nymc_fac_pubs-2858","doi":null,"is_oa":false,"landing_page_url":"https://touroscholar.touro.edu/nymc_fac_pubs/1976","pdf_url":null,"source":{"id":"https://openalex.org/S4377196437","display_name":"Touro Scholar (Touro College)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I200437953","host_organization_name":"Touro College","host_organization_lineage":["https://openalex.org/I200437953"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"NYMC Faculty Publications","raw_type":"article"},{"id":"pmh:oai:doaj.org/article:5c1b5039e9ed40a3af76e91e8bf985ed","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/5c1b5039e9ed40a3af76e91e8bf985ed","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Neuropsychiatric Disease and Treatment, Vol Volume 15, Pp 247-257 (2019)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/43591","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/brexpiprazole-for-the-maintenance-treatment-of-adults-with-schizophren-peer-reviewed-article-NDT","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Review"}],"best_oa_location":{"id":"doi:10.2147/ndt.s169369","doi":"https://doi.org/10.2147/ndt.s169369","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ndt.s169369","pdf_url":"https://www.dovepress.com/getfile.php?fileID=47538","source":{"id":"https://openalex.org/S124245730","display_name":"Neuropsychiatric Disease and Treatment","issn_l":"1176-6328","issn":["1176-6328","1178-2021"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychiatric Disease and Treatment","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309652","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2910694408.pdf","grobid_xml":"https://content.openalex.org/works/W2910694408.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W1868790909","https://openalex.org/W1923219172","https://openalex.org/W1990121386","https://openalex.org/W2089001223","https://openalex.org/W2120893202","https://openalex.org/W2133171295","https://openalex.org/W2140725933","https://openalex.org/W2151839057","https://openalex.org/W2165202919","https://openalex.org/W2274260754","https://openalex.org/W2295051011","https://openalex.org/W2323689383","https://openalex.org/W2482680139","https://openalex.org/W2513889801","https://openalex.org/W2536022106","https://openalex.org/W2586571825","https://openalex.org/W2768487721","https://openalex.org/W2793227676","https://openalex.org/W2794623194","https://openalex.org/W2801936717","https://openalex.org/W2804126510","https://openalex.org/W2820534430","https://openalex.org/W2884924211","https://openalex.org/W2887818390","https://openalex.org/W2896776930","https://openalex.org/W2900681377","https://openalex.org/W2925768352"],"related_works":["https://openalex.org/W2235815141","https://openalex.org/W2592612953","https://openalex.org/W2513889801","https://openalex.org/W2911276883","https://openalex.org/W2199930390","https://openalex.org/W7154028145","https://openalex.org/W3112124269","https://openalex.org/W2517792313","https://openalex.org/W4413831348","https://openalex.org/W2945275522"],"abstract_inverted_index":{"Abstract:":[0],"The":[1,86],"purpose":[2],"of":[3,18,99,131,137,165,176,185,206,211,226,256],"this":[4],"review":[5],"is":[6,45,160,248,259],"to":[7,32,112,147,168,189,216],"describe":[8],"the":[9,15,26,50,96,108,116,123,134,142,181,186,198,209,224,239,253],"available":[10,199],"data":[11,156,244],"for":[12,68,95,223,252],"brexpiprazole":[13,44,135,159,179,247],"in":[14,49,63,90,107,115,133,141,180,191,219,238],"maintenance":[16,97,183,254],"treatment":[17,98,225,255],"schizophrenia.":[19,227],"This":[20],"objective":[21],"was":[22,214],"completed":[23],"by":[24],"searching":[25],"databases":[27],"PubMed,":[28],"Embase,":[29],"and":[30,72,92,104,208,229],"ClinicalTrials.gov":[31],"identify":[33],"relevant":[34],"study":[35],"results":[36],"presented":[37],"as":[38],"papers":[39],"or":[40],"abstracts.":[41],"In":[42,197],"summary,":[43],"a":[46,58,192],"new":[47],"agent":[48,251],"D":[51,83],"2":[52,84],"partial":[53],"agonist":[54],"class":[55],"that":[56,158,172,217,246,258],"has":[57],"unique":[59],"receptor-binding":[60],"profile,":[61],"based":[62],"part":[64],"on":[65],"high":[66],"affinity":[67],"serotonin":[69],"5HT":[70,73],"1A":[71],"2A":[74],"receptors,":[75],"paired":[76],"with":[77,163,221],"lower":[78],"intrinsic":[79],"activity":[80],"at":[81],"dopamine":[82],"receptors.":[85],"average":[87],"dose":[88],"used":[89],"efficacy":[91],"safety":[93,110,195,241],"studies":[94,111,220],"schizophrenia":[100,257],"ranged":[101,173],"from":[102,122,174],"3.0":[103],"3.1":[105],"mg":[106,114],"open-label":[109,194,240],"3.6":[113],"double-blind":[117,125,182],"randomized":[118],"relapse-prevention":[119,127,187],"study.":[120,196],"Highlights":[121],"52-week":[124,193],"placebo-controlled":[126],"trial":[128,188],"evidenced":[129],"rates":[130,164,205],"relapse":[132,271],"group":[136,144],"13.5%":[138],"vs":[139],"38.5%":[140],"placebo":[143],"(number":[145],"needed":[146],"treat":[148],"4,":[149],"95%":[150],"CI":[151],"3\u20138;":[152],"P":[153],"<0.0001).":[154],"Safety":[155],"indicate":[157,245],"tolerated":[161],"well,":[162],"discontinuation":[166],"due":[167],"treatment-emergent":[169],"adverse":[170],"events":[171],"5.2%":[175],"those":[177],"taking":[178],"phase":[184],"15.3%":[190],"trials,":[200],"there":[201],"were":[202],"relatively":[203,236],"low":[204],"akathisia,":[207,264],"degree":[210],"weight":[212,265],"gain":[213],"similar":[215],"seen":[218],"aripiprazole":[222],"Positive":[228],"Negative":[230],"Syndrome":[231],"Scale":[232],"scores":[233],"also":[234],"remained":[235],"stable":[237],"studies.":[242],"Available":[243],"an":[249],"effective":[250],"overall":[260],"well":[261],"tolerated.":[262],"Keywords:":[263],"gain,":[266],"second-generation":[267],"antipsychotics,":[268,270],"atypical":[269],"prevention":[272]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2910694408","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":164},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2019-01-25T00:00:00"}
